BioSpace News Archive

TARIS Bio™, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today that Tony Kingsley has joined the company as president and chief executive officer and was elected to the TARIS board of directors.

Riley will be on a panel moderated by NBC News Anchor Richard Lui, and with senior executives from Embodied Labs, Dthera Sciences and Ageless Innovation -- Joy for All Companion Pets, to discuss the growing use of technology for the treatment and management of Alzheimer’s Disease.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, today announced that it has appointed Eric B. Mosbrooker as Senior Vice President and Chief Commercial Officer.

Pliant Therapeutics, Inc., a biotechnology company unraveling and targeting the key biological pathways driving fibrosis, today announced that Keith Cummings, M.D., MBA, has joined the company as chief financial officer and Eduard Gorina, M.D., has joined as vice president, clinical development.

Ophthotech Corporation (NASDAQ: OPHT) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will present an overview of the Company at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Heron Therapeutics (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced results of a multi-center postoperative pain management study in which 63 patients undergoing hernia repair surgery received the investigational agent, HTX-011, together with a regimen of generic over-the-counter (OTC) oral analgesics (acetaminophen and ibuprofen).

Neurotrope (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), today announced that Daniel Alkon, M.D., Neurotrope’s President and Chief Scientific Officer, will be participating in a panel discussion entitled “Progress in Alzheimer’s” at the Sachs Associates 2nd Annual Neuroscience Innovation Forum in San Francisco on Sunday, January 6th, 2019

The law firm of Karst & von Oiste is a leading national law firm focused on the best possible financial compensation for people with mesothelioma or asbestos exposure lung cancer.

LabCorp® announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

Collagen Solutions & Berkshire Sterile Manufacturing to Supply Excellagen® for Q1 Launch